Thursday , August 5 2021

11 city centralized purchase of drugs proposed election results publicly announced drug prices fell an average of 52% – News



11 centralized drug purchase of the city proposed election results

Drug prices fell by an average of 52%

Beijing, December 8, reporter Wu Jiajia reported: The National Medical Insurance Bureau said on the 8th that the national centralized pilot drug procurement work progressed smoothly, and the results of the city's centralized drug acquisition plan 4 + 7 were announced on 7, 31 The generic pilot drug has 25 centralized procurement plans and, compared to the minimum purchase price of the same drug in the pilot city in 2017, the average price of the proposed price fell 52%, with the largest fall of 96%.

It is understood that the centralized procurement of this round of drugs is based in Beijing, Tianjin, Shanghai, Chongqing and Shenyang, Dalian, Xiamen, Guangzhou, Shenzhen, Chengdu, Xi'an 11 public health institutions as the main procurement body centralized, forming an alliance of acquisitions. The Joint Procurement Department brought together the dispersed purchases of medicines from public hospitals in 11 pilot cities to form a large-scale group buying effect. In the procurement announcement, the purchase value of each variety was specified, and pharmaceutical manufacturers would clearly benefit from the acquisition. The independent quotation statement eliminates the phenomenon of "selling with gold," it is beneficial to change the price by quantity, to significantly reduce the price of medicines, and to effectively reduce the burden of drug expenses for patients, and it is beneficial to reduce inter-marketing costs of companies. At the same time, this centralized procurement pilot offers opportunities for fair competition between generic drugs and original research drugs through a consistency assessment that is conducive to strengthening competition and promoting the replacement of generic drugs.

The person in charge of the Joint Procurement Office pointed out that pharmaceutical companies attach great importance to this centralized procurement, and all eligible companies participate in the statement, reflecting the enthusiasm of the companies participating in the national centralized drug procurement pilot organization. In the end, there were 25 generic drugs centralized for 31 generic generic drugs, with a success rate of 81%. Among them: 22 generic drugs passed the consistency assessment, representing 88%, and 3 original medicines, representing 12%, and the generic drug substitution effect appeared. Compared with the minimum purchase price of the same drug in the pilot city in 2017, the average price of the proposed price fell 52%, with the largest drop of 96%. After the end of the advertising period, the company will determine and publish the results of the election. The pilot office will guide and promote pilot programs and pilot cities support policies, deliver on the results of the bid, and realize the benefits of the masses.

Why is there a sharp drop in the price of the drug to be selected? A sharp cut in prices will have a negative impact on pharmaceutical manufacturers? The person in charge of the Joint Procurement Office pointed out that the overall decline in the price of the drug selected for centralized procurement of medicines in the country was in line with expectations, demonstrating the strength of alliance acquisition and quantity acquisition. The masses can get high-quality, low-priced drugs, and production companies can also save transaction costs and focus on R & D to capture quality. "The high price of the drug is a prominent problem in the field of medicine in China. According to the authoritative department's research data, in the drug sale price, the production company's reasonable cost of production and profit represents only a small Therefore, the price of the drug to be pre-selected is planned. After a drastic fall, the main reason for the tightening is the "humidity", such as selling expenses, and pharmaceutical manufacturers can still "The responsible person has revealed that participating in the" 4 + 7 centralized acquisition "and the purchase quote is based on the company.The production and operation situation is determined on its own.It is understood that the companies to be selected are willing to reduce the price per price.

The person in charge of the joint purchasing department also said that the price of the selected drug fell dramatically. For pharmaceutical companies, the current non-profit and long-term benefits are good. First, the volume of purchases has greatly reduced the cost of drugs entering the hospital. Second, the promise of timely payments reduces corporate spending and financing costs. Third, acquiring alliances significantly lowers your marketing costs. Fourth, to change the market price, the unit cost of producing the drug is reduced by the scale effect. These factors can protect the impact of drug price cuts and bring tangible benefits to selected companies. The large-scale purchasing model promoted by the national centralized drug procurement organization frees drug manufacturers from the disorderly "sell with gold" competition, which leads them to shift their efforts to improve drug quality and promote the right path of research and development. It has far-reaching significance for the healthy development of China's pharmaceutical industry.

In addition, the person in charge of the pilot's office said that ensuring the selection of medicines for the hospital and obtaining priority use is the key to the success of the national centralized drug procurement pilot organization. The next step is to include drug use in the management of health insurance contracts and clarify the liability for breach of contract and how to deal with them. The second is to introduce a standard payment policy. To clarify medical insurance for drugs with the same common name and different commodity names, the operating rules and transition policies paid according to the same payment standard, and guide the insured to the rational use of drugs. The third is to strengthen the monitoring and control of procurement of selected and unselected drugs and find measures to address the abnormal situation in a timely manner. Fourth, hospitals that reduce the expense of medical insurance funds due to the use of varieties selected in the standard When the total amount of health insurance budget is not reduced, the balance is reserved to hospital proportionally to promote reform of the health insurance distribution system salaries of the hospital and mobilize the enthusiasm of medical personnel. The fifth is to establish and improve the health insurance assessment and evaluation system of medical institutions and to incorporate the use of selected drugs into the health insurance assessment and evaluation system, and establish corresponding reward and punishment systems.

Wu Jiajia


Source link